Diagnosis and Management of Posttransplant Lymphoproliferative Disorder in Solid‐Organ Transplant Recipients
Open Access
- 1 July 2001
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 33 (s1) , S38-S46
- https://doi.org/10.1086/320903
Abstract
The Epstein-Barr virus (EBV) has a pivotal pathophysiologic role in the development of most lymphoproliferative disorders that occur after solid-orgaKeywords
This publication has 93 references indexed in Scilit:
- MANAGEMENT OF POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE IN PEDIATRIC LIVER TRANSPLANT RECIPIENTS RECEIVING PRIMARY TACROLIMUS (FK506) THERAPYTransplantation, 1998
- Development of monoclonal gammopathy precedes the development of Epstein-Barr virus-induced posttransplant lymphoproliferative disorderLiver Transplantation and Surgery, 1996
- Transmission of donor Epstein--Barr virus (EBV) in transplanted organs causes lymphoproliferative disease in EBV-seronegative recipientsJournal of General Virology, 1996
- POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER IN RENAL ALLOGRAFT RECIPIENTSTransplantation, 1993
- Quantitative Oropharyngeal Epstein-Barr Virus Shedding in Renal and Cardiac Transplant Recipients: Relationship to Immunosuppressive Therapy, Serologic Responses, and the Risk of Posttransplant Lymphoproliferative DisorderThe Journal of Infectious Diseases, 1992
- Lymphoproliferative disorder early after cardiac transplantationThe American Journal of Cardiology, 1991
- POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE OF THE LIVER SUCESSFULLY TREATED BY RETRANSPLANTATIONTransplantation, 1991
- Treatment of B-Cell Lymphoproliferative Disorders with Interferon Alfa and Intravenous Gamma GlobulinNew England Journal of Medicine, 1988
- LYMPHOMAS AND LYMPHOPROLIFERATIVE LESIONS DEVELOPING UNDER CYCLOSPORIN THERAPYThe Lancet, 1984
- Epstein–Barr Virus-Induced B-Cell Lymphoma after Renal TransplantationNew England Journal of Medicine, 1982